Biohaven Ltd
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
公司地址 c/o Biohaven Pharmaceuticals, Inc, 215 Church Street, New Haven, CT, USA, 06510
電話號碼 +1 203 404-0410
傳真號碼 --
公司網頁 https://www.biohaven.com
員工數量 274
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. William B.J. Jones, M.D. Chief Commercial Officer, Migraine and Common Diseases 美元 507.15K 11/03/2022
Mr. Bruce Car Chief Scientific Officer 美元 515.57K 18/03/2025
Ms. Kimberly Gentile Senior Vice President, Clinical Operations 美元 489.31K 18/03/2025
Mr. Charles Conway Chief Scientific Officer -- 11/03/2022
Dr. Vlad Coric, M.D. Chief Executive Officer and Chairman of the Board 美元 885.00K 02/03/2026
Mr. George C. Clark Chief Accounting Officer and Vice President -- 02/03/2026
Mr. Matthew Buten Chief Financial Officer 美元 573.30K 02/03/2026
 
董事會成員
董事會 職務 更新日期
Ms. Julia P. Gregory Independent Director 02/03/2026
Dr. Gregory Hugh Bailey, M.D. Independent Director 02/03/2026
Mr. Robert J. Hugin Independent Director 02/03/2026
Mr. Michael T. Heffernan, R.Ph. Lead Independent Director 02/03/2026
Mr. John W. Childs Independent Director 02/03/2026
Dr. Vlad Coric, M.D. Chief Executive Officer and Chairman of the Board 02/03/2026
Mr. Michael Hefferenan Director 25/02/2022
Mr. Kishan Mehta Director 02/03/2026
Dr. Irina Antonijevic, M.D.,PhD Independent Director 02/03/2026
 
所屬ETF (更新日期: 07/03/2026 04:09)
代號 名稱 佔比% ▼ 持有日期
XBIState Street® SPDR® S&P® Biotech ETF2.30%27/02/2026
PINKSimplify Health Care ETF0.69%27/02/2026
IBBiShares Biotechnology ETF0.55%28/02/2026
HQLabrdn Life Sciences Investors0.46%31/01/2026
SCHASchwab US Small-Cap ETF™0.37%28/02/2026
VTWOVanguard Russell 2000 ETF0.30%31/01/2026
VHTVanguard Health Care ETF0.23%31/01/2026
FESMFidelity Enhanced Small Cap ETF0.16%27/02/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.11%28/02/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.10%27/02/2026
LABUDirexion Daily S&P Biotech Bull 3X ETF0.10%26/02/2026
NUSCNuveen ESG Small-Cap ETF0.08%27/02/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.07%28/02/2026
VTWGVanguard Russell 2000 Growth ETF0.06%31/01/2026
VTVanguard Total World Stock ETF0.04%31/01/2026
FHLCFidelity MSCI Health Care ETF0.03%28/02/2026
BMEZBlackRock Health Sciences Term Trust0.03%31/12/2025
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.03%27/02/2026
ISMDInspire Small/Mid Cap ETF0.03%27/02/2026
SCHBSchwab US Broad Market ETF™0.02%28/02/2026
 1    2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.